Lista de obras - Palle B. Jeppesen - Dominio Público Uruguay

Acute Effects of the Glucagon-Like Peptide 2 Analogue, Teduglutide, On Intestinal Adaptation in Newborn Pigs With Short Bowel Syndrome

scientific article published on 01 June 2014

Adult Patients Receiving Home Parenteral Nutrition in Denmark from 1991 to 1996: Who Will Benefit from Intestinal Transplantation? ⬇️

artículo científico publicado el 1 de agosto de 1998

Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome

scientific article published on 01 August 1999

Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

artículo científico publicado en 2007

Bovine Colostrum to Children With Short Bowel Syndrome

article

Butyrate absorption and lactate secretion in ulcerative colitis

artículo científico publicado en 1995

Catheter-Related Bloodstream Infections in Adults Receiving Home Parenteral Nutrition: Substantial Differences in Incidence Comparing a Strict Microbiological to a Clinically Based Diagnosis

article published in 2017

Catheter-related bloodstream infections in patients with intestinal failure receiving home parenteral support: risks related to a catheter-salvage strategy

artículo científico publicado en 2018

Clinical nutrition in the hepatogastroenterology curriculum.

artículo científico publicado en 2016

Clinical significance of GLP-2 in short-bowel syndrome.

artículo científico publicado en 2003

Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure.

artículo científico publicado en 1999

Corrigendum to "ESPEN guidelines on chronic intestinal failure in adults" [Clin Nutr 35 (2) (2016) 247-307].

artículo científico publicado en 2016

Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure

artículo científico publicado en 2000

Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale.

artículo científico publicado en 2012

Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption

artículo científico publicado en 1999

Differences in methodology impact estimates of survival and dependence on home parenteral support of patients with nonmalignant short bowel syndrome

artículo científico publicado en 2020

ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients

scientific article published on 22 May 2009

ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

artículo científico publicado en 2014

Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open-Label Pilot Study.

artículo científico publicado en 2016

Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure

artículo científico publicado en 2012

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial

scientific article published on 17 July 2019

Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

artículo científico publicado en 2008

Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.

artículo científico publicado en 2000

Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials

scientific article published on 18 August 2019

Essential fatty acid deficiency in patients receiving home parenteral nutrition

scientific article published on 01 July 1998

Essential fatty acid deficiency in patients with severe fat malabsorption

scientific article published on 01 March 1997

Etiology and epidemiology of catheter related bloodstream infections in patients receiving home parenteral nutrition in a gastromedical center at a tertiary hospital in denmark

artículo científico publicado en 2012

European Society of Coloproctology consensus on the surgical management of intestinal failure in adults

artículo científico publicado en 2016

Experimental approaches: dietary and hormone therapy.

artículo científico publicado en 2003

Factors Associated with Response to Teduglutide in Patients With Short-bowel Syndrome and Intestinal Failure.

artículo científico publicado en 2017

Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72-Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure

artículo científico publicado en 2017

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

scientific article published on 15 March 2019

Glucagon like peptide-2 and neoplasia; a systematic review.

artículo científico publicado en 2017

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

artículo científico publicado en 2001

Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates

artículo científico publicado en 2013

Glucagon-like peptide-2: update of the recent clinical trials.

artículo científico publicado en 2006

Growth factors in short-bowel syndrome patients.

artículo científico publicado en 2007

Gut hormones in the treatment of short-bowel syndrome and intestinal failure

artículo científico

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center

artículo científico publicado en 2016

Human rectal absorption of short- and medium-chain C2-C10 fatty acids

artículo científico publicado en 1998

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

scientific article published on 25 July 2018

Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

scientific article published on 21 April 2019

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

artículo científico publicado en 1999

In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans

artículo científico publicado en 2000

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.

artículo científico publicado en 2016

Intestinal failure defined by measurements of intestinal energy and wet weight absorption

artículo científico publicado en 2000

Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection

scientific article published on 01 February 2001

Intestinal insufficiency and failure.

artículo científico publicado en 2003

Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome

artículo científico publicado en 2016

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants

artículo científico publicado en 2014

Minimal Enteral Nutrition to Improve Adaptation After Intestinal Resection in Piglets and Infants.

artículo científico publicado en 2017

Modern treatment of adult short bowel syndrome patients.

artículo científico

Modern treatment of short bowel syndrome.

artículo científico

New approaches to the treatments of short bowel syndrome-associated intestinal failure.

artículo científico

Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.

artículo científico publicado en 2018

Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum

scientific article published on 06 January 2019

Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic Intestinal Failure

artículo científico publicado en 2017

Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents

artículo científico publicado en 2007

Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome

artículo científico

Plasma phospholipid fatty acid pattern in severe liver disease

artículo científico publicado en 2000

Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected 125I-GLP-2

artículo científico publicado en 2000

Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition

artículo científico publicado en 2018

Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome

artículo científico publicado en 2012

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome ⬇️

artículo científico publicado el 11 de febrero de 2011

Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract

scientific article published on 01 August 2008

Reply to AL Buchman

artículo científico publicado en 2018

Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure

artículo científico publicado en 2013

Serum carotenoids and macular pigment optical density in patients with intestinal resections and healthy subjects: an exploratory study.

artículo científico publicado en 2018

Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care.

artículo científico

Short-bowel syndrome treated with glucagon-like peptide. 2. The Danish Society for Gastroenterology

artículo científico publicado en 2008

Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

artículo científico publicado en 2002

Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition.

artículo científico publicado en 1998

Single-Center, Adult Chronic Intestinal Failure Cohort Analyzed According to the ESPEN-Endorsed Recommendations, Definitions, and Classifications.

artículo científico publicado en 2015

Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure.

artículo científico

Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial

artículo científico publicado en 2017

Teduglutide for the treatment of short bowel syndrome

scientific article published on 01 October 2013

Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure

artículo científico publicado en 2012

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome

artículo científico publicado en 2012

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

artículo científico publicado en 2011

The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: a systematic review.

artículo científico publicado en 2017

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice

artículo científico publicado en 2017

The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection.

artículo científico publicado en 1998

The novel use of peptide analogs in short bowel syndrome.

artículo científico publicado en 2013

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

artículo científico publicado en 2002

The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.

artículo científico publicado en 2006

The use of metabolic balance studies in the objective discrimination between intestinal insufficiency and intestinal failure.

artículo científico publicado en 2017

Treatment of adult short bowel syndrome patients with teduglutide

artículo científico

Understanding incretins

artículo científico publicado en 2014

Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery

scientific article published on 01 May 1995

Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection ⬇️

artículo científico publicado el 1 de mayo de 2003

Lista de obras de Palle B. Jeppesen

Acute Effects of the Glucagon-Like Peptide 2 Analogue, Teduglutide, On Intestinal Adaptation in Newborn Pigs With Short Bowel Syndrome

Adult Patients Receiving Home Parenteral Nutrition in Denmark from 1991 to 1996: Who Will Benefit from Intestinal Transplantation? ⬇️

Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome

Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

Bovine Colostrum to Children With Short Bowel Syndrome

Butyrate absorption and lactate secretion in ulcerative colitis

Catheter-Related Bloodstream Infections in Adults Receiving Home Parenteral Nutrition: Substantial Differences in Incidence Comparing a Strict Microbiological to a Clinically Based Diagnosis

Catheter-related bloodstream infections in patients with intestinal failure receiving home parenteral support: risks related to a catheter-salvage strategy

Clinical nutrition in the hepatogastroenterology curriculum.

Clinical significance of GLP-2 in short-bowel syndrome.

Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure.

Corrigendum to "ESPEN guidelines on chronic intestinal failure in adults" [Clin Nutr 35 (2) (2016) 247-307].

Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure

Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale.

Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption

Differences in methodology impact estimates of survival and dependence on home parenteral support of patients with nonmalignant short bowel syndrome

ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients

ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open-Label Pilot Study.

Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial

Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.

Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials

Essential fatty acid deficiency in patients receiving home parenteral nutrition

Essential fatty acid deficiency in patients with severe fat malabsorption

Etiology and epidemiology of catheter related bloodstream infections in patients receiving home parenteral nutrition in a gastromedical center at a tertiary hospital in denmark

European Society of Coloproctology consensus on the surgical management of intestinal failure in adults

Experimental approaches: dietary and hormone therapy.

Factors Associated with Response to Teduglutide in Patients With Short-bowel Syndrome and Intestinal Failure.

Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72-Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Glucagon like peptide-2 and neoplasia; a systematic review.

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates

Glucagon-like peptide-2: update of the recent clinical trials.

Growth factors in short-bowel syndrome patients.

Gut hormones in the treatment of short-bowel syndrome and intestinal failure

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center

Human rectal absorption of short- and medium-chain C2-C10 fatty acids

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Intestinal failure defined by measurements of intestinal energy and wet weight absorption

Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection

Intestinal insufficiency and failure.

Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants

Minimal Enteral Nutrition to Improve Adaptation After Intestinal Resection in Piglets and Infants.

Modern treatment of adult short bowel syndrome patients.

Modern treatment of short bowel syndrome.

New approaches to the treatments of short bowel syndrome-associated intestinal failure.

Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.

Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum

Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic Intestinal Failure

Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents

Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome

Plasma phospholipid fatty acid pattern in severe liver disease

Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected 125I-GLP-2

Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition

Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome ⬇️

Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract

Reply to AL Buchman

Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure

Serum carotenoids and macular pigment optical density in patients with intestinal resections and healthy subjects: an exploratory study.

Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care.

Short-bowel syndrome treated with glucagon-like peptide. 2. The Danish Society for Gastroenterology

Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition.

Single-Center, Adult Chronic Intestinal Failure Cohort Analyzed According to the ESPEN-Endorsed Recommendations, Definitions, and Classifications.

Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure.

Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial

Teduglutide for the treatment of short bowel syndrome

Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients